Serum obtained from mice 3 to 5 days after cytomegalovirus infection contained complement-requiring neutralizing antibody, which, when passively transferred, protected mice from lethal infection with the homologous virus. The active substance was largely heat-stable 7s immunoglobulin.
Mannini and Medearis (5) showed that SwissWebster mice infected with murine cytomegalovirus (MCMV) did not develop neutralizing antibodies until 19 to 26 days after infection. Starr and Allison (8) showed that serum obtained from mice 6 days after infection did not passively protect mice from death 24 h after inoculation with MCMV. At the same time, immune spleen cells from such animals protected. MCMV has been reported to suppress the primary response to sheep erythrocytes (7) and to destroy germinal centers in the spleen within the first week of infection (4) . The question of whether specific humoral immunity is stimulated during the acute infection arises. The following report describes the protective effect of serum obtained 3 to 5 days after infection and shows that protection is probably due to specific immunoglobulin.
MATERIALS AND METHODS
Virus. The Smith strain of MCMV was obtained from June Osborn. Virus stocks were prepared from the salivary glands of mice 3 weeks after infection. Outbred albino CD-1 mice (Charles River Breeding Laboratories, Wilmington, Mass.), 2 to 8 weeks old, were used. To titrate MCMV, 20% organ homogenates were serially diluted with medium 199, and 0.1-ml samples of each dilution were inoculated on duplicate wells of mouse embryo cell cultures (MECC). After 90 min of absorption at 370C under 5% C02, tragacanth gum overlay was added to each well (6) . Cultures were incubated for 7 to 9 days. The overlay was aspirated off, and the cell sheets were stained with gentian violet for plaque counting.
Cell culture. Pregnant mice (CD-1 strain) were used for MECC. Primary MECC were prepared from mouse embryos in Povitsky bottles and grown in medium 199, supplemented with 5% newborn calf serum and antibiotics. After To characterize complement-requiring antibodies, 5-and 39-day anti-MCMV sera were treated with mercaptoethanol and tested for neutralizing activity in the presence and absence of complement. Neutralizing activity was not significantly reduced after treatment with mercaptoethanol, suggesting that the neutralizing antibodies were largely associated with the 7s immunoglobulins.
IgM and IgG fractions were obtained from early and late antisera by KBr-NaNO3 gradient centrifugation. By immunodiffusion, the lowmolecular-weight or IgG fraction contained IgG without IgM. The high-molecular-weight or IgM fraction contained IgM and trace amounts of 
